Dr. Agarwal's Health Care Limited AGARWALEYE

Latest filings

• Routine15 11 Nov, 15:13 · BSE
  Transcript of the Discussion held on the Unaudited Financial Results (Consolidated & Standalone) of the Company for the quarter and half year ended September 30, 2026, at the analyst call ....
• Routine15 5 Nov, 20:19 · BSE
  Link for the Audio recording of the Analyst / Earnings Conference call held on the Unaudited Financial Results (Consolidated and Standalone) of the Company for the quarter and half year ....
• Routine15 5 Nov, 19:56 · BSE
  Dr. Agarwal's Health Care Limited - Monitoring Agency Report for the quarter ended September 30, 2026, is submitted
• — 5 Nov, 19:37 · NSE
  Corrigendum to the Outcome of Board Meeting held on November 05, 2026, is submitted
• Routine15 5 Nov, 19:35 · BSE
  Corrigendum to the Outcome of Board Meeting held on November 05, 2026, is submitted
• Routine15 5 Nov, 19:15 · NSE
  Allotment of 54,728 Equity Shares pursuant to the exercise of options granted under Dr. Agarwal's Health Care Limited - Employees Stock Option Scheme 2022
• Management change70 5 Nov, 18:16 · NSE
  Appointment and Re-designation of Dr. Amar Agarwal, Chairman and Non-Executive Director of the Company, as the Executive Chairman (Whole-Time Director) of the Company
• Routine15 5 Nov, 18:11 · NSE
  Investor Presentation
• Results76 5 Nov, 18:00 · NSE
  Board Meeting Outcome for Consolidated And Standalone Unaudited Financial Results For The Quarter and Half Year Ended September 30, 2026 And Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
• Board meeting48 5 Nov, 17:58 · BSE
  Outcome of the Meeting of the Board of Directors of the Company held on November 05, 2026, is attached.

Shown 15 minutes after publication. Real time with Pro.